Author: Jessica.F

In 2008,Primas, Nicolas; Bouillon, Alexandre; Lancelot, Jean-Charles; Sopkova-de Oliveira Santos, Jana; Lohier, Jean-Francois; Rault, Sylvain published 《A new methodology to prepare 2-halogenoimidazoles via a N-THP protection》.Letters in Organic Chemistry published the findings.Recommanded Product: 16681-56-4 The information in the text is summarized as follows:

A straightforward access to 2-halogenoimidazoles via a N-THP protection was described in this paper. The N-THP protecting group is easily introduced by reaction of 2-chloro-THP with imidazole. Lithiation followed by reaction with an appropriate electrophile affords 2-halogeno N-THP derivatives The THP protecting group is then cleaved to get the title compounds in good to high yields. The structures of the compounds were confirmed by x-ray diffraction anal. (data not given). In the part of experimental materials, we found many familiar compounds, such as 2-Bromo-1H-imidazole(cas: 16681-56-4Recommanded Product: 16681-56-4)

2-Bromo-1H-imidazole(cas: 16681-56-4) is a member of imidazole. Its exclusive structural characteristics with enviable electron-rich features are favorable for imidazole-based fused heterocycles to bind efficiently with an array of enzymes and receptors in biological systems through various weak interactions like hydrogen bonds, ion-dipole, cation-π, π-π stacking, coordination, Van der Waals forces, hydrophobic effects, etc., and therefore they demonstrate widespread bioactivities. Recommanded Product: 16681-56-4

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

In 2017,Tian, Junjun; Vandermosten, Leen; Peigneur, Steve; Moreels, Lien; Rozenski, Jef; Tytgat, Jan; Herdewijn, Piet; Van den Steen, Philippe E.; De Jonghe, Steven published 《Astemizole analogues with reduced hERG inhibition as potent antimalarial compounds》.Bioorganic & Medicinal Chemistry published the findings.Quality Control of 2-Chloro-1H-benzo[d]imidazole The information in the text is summarized as follows:

Astemizole is a H1-antagonist endowed with antimalarial activity, but has hERG liabilities. Systematic structural modifications of astemizole led to the discovery of analogs that display very potent activity as inhibitors of the growth of the Plasmodium parasite, but show a decreased hERG inhibition, when compared to astemizole. These compounds can be used as starting point for the development of a new class of antimalarials.2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1Quality Control of 2-Chloro-1H-benzo[d]imidazole) was used in this study.

2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1) binds to monoclonal antibodies, inhibiting their binding to their corresponding antigens. This activity may be due to its ability to bind covalently with amino groups on proteins and other molecules.Quality Control of 2-Chloro-1H-benzo[d]imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

In 2017,Garzon, Miguel; Arce, Elsa M.; Reddy, Raju Jannapu; Davies, Paul W. published 《General Entry into o-,o’-Heteroatom-Linked N-(Hetero)aryl-Imidazole Motifs by Gold-Catalysed Formal [3+2]-Dipolar Cycloaddition》.Advanced Synthesis & Catalysis published the findings.Recommanded Product: 2-Chloro-1H-benzo[d]imidazole The information in the text is summarized as follows:

A general redox-neutral approach into the o-,o’-heteroatom-linked N-(hetero)aryl-imidazole family of heteroaromatics was developed. New types of heteroatom substituted carbimidoyl nitrenoids were efficiently realized from robust, bench-stable N-(heteroaryl)-pyridinium-N-aminides by formal gold-catalyzed [3+2]-dipolar cycloadditions across ynamides. Broad structural variety and functional group tolerance allowed rapid access into diverse functionalized scaffolds, as exemplified by the preparation of 8 different heteroaromatic cores. After reading the article, we found that the author used 2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1Recommanded Product: 2-Chloro-1H-benzo[d]imidazole)

2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1) is an analog of benzimidazole that has been synthesized by Langmuir adsorption isotherm. It is a white crystalline solid that can be dissolved in water and hydrochloric acid. 2-Chloro-1H-benzo[d]imidazole inhibits the growth of herpes simplex virus by acting as a competitive inhibitor for the viral enzyme thymidine kinase, which catalyzes the conversion of thymine to thymidine.Recommanded Product: 2-Chloro-1H-benzo[d]imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

In 2019,Applied Microbiology and Biotechnology included an article by Le, Quan; Nguyen, Vyncent; Park, Sheldon. Application In Synthesis of 5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid. The article was titled 《Recent advances in the engineering and application of streptavidin-like molecules》. The information in the text is summarized as follows:

Streptavidin (SA), and other related proteins, has been isolated from a wide range of organisms, including bacteria, fungi, frogs, fish, and birds. Although their original function is not well understood, they have found an important place in biotechnol. based on their unique ability to bind biotin mols. with high affinity and specificity. The SA-biotin interaction is robust and easy to incorporate into different designs, and as such, it is used when reliable mol. interaction is needed under poorly controlled exptl. conditions. There are continued efforts to engineer these proteins to modulate their size, valency, and affinity, since the optimum mol. properties vary depending on individual applications. This review will describe recent developments in streptavidin engineering to meet these requirements, including those that form novel oligomeric states, e.g., a monomer, have fewer functional biotin-binding sites, or bind biotin with reduced affinity. We also examine various reported applications of both natural or engineered SA constructs in cell biol., biochem., genetics, synthetic chem., cancer therapy, drug delivery, and nanotechnol. to illustrate the breadth of modern science that is advanced by the endogenous and engineered SA-biotin interactions. In the experiment, the researchers used 5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid(cas: 58-85-5Application In Synthesis of 5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid)

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid(cas: 58-85-5) may be used to elute proteins from avidin/streptavidin resins. It has been used for culturing of oligodendrocytes.Application In Synthesis of 5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid The biotin/avidin or biotin/streptavidin interaction is utilized in many labeling and purification schemes.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

In 2019,Current Organic Synthesis included an article by Damghani, Fatemeh K.; Pourmousavi, Seied A.; Kiyani, Hamzeh. COA of Formula: C7H7N3. The article was titled 《Sulfonic Acid-Functionalized Magnetic Nanoparticles as an Efficient Catalyst for the Synthesis of Benzo[4,5]imidazo[1,2-a]pyrimidine derivatives, 2-Aminobenzothiazolomethylnaphthols and 1-Amidoalkyl-2-naphthols》. The information in the text is summarized as follows:

Three Fe3O4@C-SO3H were successfully prepared by solvothermal carbonization of sucrose (Suc), starch (Sta) or cellulose (Cel) in the presence of Fe3O4 nanoparticle and then grafting of the sulfonic groups on the surface of resulted Fe3O4@C nanoparticles in the presence of p-toluenesulfonic acid. Then the nano catalysts were characterized using XRD, FESEM and FT-IR. The resulted MNPs were used for the one-pot synthesis of benzo[4,5]imidazo[1,2-a]pyrimidine derivatives, 2-aminobenzothiazolomethylnaphthols and 1-amidoalkyl-2-naphthols under solvent-free conditions in excellent yields. It was found that high catalytic activity and easy magnetic separation from the reaction mixture are important achievement with regard to the efficiency and reusability of the catalyst in synthesis. In the experimental materials used by the author, we found 1H-Benzo[d]imidazol-2-amine(cas: 934-32-7COA of Formula: C7H7N3)

1H-Benzo[d]imidazol-2-amine(cas: 934-32-7) can be used in the hydrolysis of a choline carbonate. It was also used in the synthesis of imidazo[1,2-a]benzimidazoles.COA of Formula: C7H7N3

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

In 2019,Bioorganic & Medicinal Chemistry included an article by Chino, Ayaka; Honda, Shugo; Morita, Masataka; Yonezawa, Koichi; Hamaguchi, Wataru; Amano, Yasushi; Moriguchi, Hiroyuki; Yamazaki, Mayako; Aota, Masaki; Tomishima, Masaki; Masuda, Naoyuki. Name: 2-Chloro-1H-benzo[d]imidazole. The article was titled 《Synthesis, SAR study, and biological evaluation of novel 2,3-dihydro-1H-imidazo[1,2-a]benzimidazole derivatives as phosphodiesterase 10A inhibitors》. The information in the text is summarized as follows:

Phosphodiesterase 10A (PDE10A) inhibitors were designed and synthesized based on the dihydro-imidazobenzimidazole scaffold. Compound I showed moderate inhibitory activity and good permeability but unfavorable high P-glycoprotein (P-gp) liability for brain penetration. An optimization study to improve both the P-gp efflux ratio and PDE10A inhibitory activity was performed. As a result, compound II was identified with improved P-gp liability and high PDE10A inhibitory activity. Compound II also showed satisfactory brain penetration, suppressed phencyclidine-induced hyperlocomotion and improved MK-801-induced working memory deficit. In addition to this study using 2-Chloro-1H-benzo[d]imidazole, there are many other studies that have used 2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1Name: 2-Chloro-1H-benzo[d]imidazole) was used in this study.

2-Chloro-1H-benzo[d]imidazole(cas: 4857-06-1) binds to monoclonal antibodies, inhibiting their binding to their corresponding antigens. This activity may be due to its ability to bind covalently with amino groups on proteins and other molecules.Name: 2-Chloro-1H-benzo[d]imidazole

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

The author of 《Imidazole and 1-Methylimidazole Hydrogen Bonding and Nonhydrogen Bonding Liquid Dynamics: Ultrafast IR Experiments》 were Shin, Jae Yoon; Wang, Yong-Lei; Yamada, Steven A.; Hung, Samantha T.; Fayer, Michael D.. And the article was published in Journal of Physical Chemistry B in 2019. Electric Literature of C4H6N2 The author mentioned the following in the article:

The dynamics of imidazole (IM) and 1-methylimidazole (1-MeIM) in the liquid phase at 95 °C were studied by IR polarization selective pump-probe and two-dimensional IR (2D IR) spectroscopies. The two mols. are very similar structurally except that IM can be simultaneously a hydrogen bond donor and acceptor and therefore forms extended hydrogen-bonded networks. The broader IR absorption spectrum and a shorter vibrational lifetime of the vibrational probe, selenocyanate anion (SeCN-), in IM vs 1-MeIM indicate that stronger hydrogen bonding exists between SeCN- and IM. Mol. dynamics (MD) simulations support the strong hydrogen bond formation between SeCN- and IM via the HN moiety. SeCN- makes two H-bonds with IM; it is inserted in the IM H-bonded chains rather than being a chain terminator. The strong hydrogen bonding influenced the reorientation dynamics of SeCN- in IM, leading to a more restricted short time angular sampling (wobbling-in-a-cone). The complete orientational diffusion time in IM is 1.7 times slower than in 1-MeIM, but the slow down is less than expected, considering the 3-fold larger viscosity of IM. The jump reorientation mechanism accounts for the anomalously fast orientational relaxation in IM, and the MD simulations determined the average jump angle of the probe between hydrogen bonding sites. Spectral diffusion time constants obtained from the 2D IR experiments are only modestly slower in IM than in 1-MeIM in spite of the significant increase in viscosity. The results indicate that the spectral diffusion sensed by the SeCN- has IM hydrogen bond dynamics contributions not present in 1-MeIM. The experimental process involved the reaction of 1-Methyl-1H-imidazole(cas: 616-47-7Electric Literature of C4H6N2)

1-Methyl-1H-imidazole(cas: 616-47-7) is actively involved in removing acid during the production of diethoxyphenylphosphine. It is used as an intermediate in organic synthesis.Electric Literature of C4H6N2

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

《A study of plasma electrolytic oxidation coatings doped with 2-ainobenzimidazole loaded halloysite nanotubes on AZ31 magnesium alloy》 was written by Wu, Wen-Xin; Lin, Hsin-Chih. HPLC of Formula: 934-32-7 And the article was included in Purazuma Oyo to Fukugo Kino Zairyo in 2020. The article conveys some information:

Plasma electrolytic oxidation (PEO) coatings with actively protective functionality by incorporating 2-aminobenzimidazole (2-ABI) loaded halloysite nanotubes (HNTs) was presented. The coatings were characterized by SEM and EDX. Corrosion behavior was evaluated by EIS measurement. With the SEM and EDX anal., the existence of HNT or 2ABI-loaded HNT was confirmed. EIS complex spectra showed the enhanced corrosion resistance of 2-ABI-HNT PEO coating, suggesting 2-ABI has good potential as corrosion inhibitor for Mg alloys.1H-Benzo[d]imidazol-2-amine(cas: 934-32-7HPLC of Formula: 934-32-7) was used in this study.

1H-Benzo[d]imidazol-2-amine(cas: 934-32-7) can be used in the hydrolysis of a choline carbonate. It was also used in the synthesis of imidazo[1,2-a]benzimidazoles.HPLC of Formula: 934-32-7

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

《Improved Coverage of Mouse Myelomeningocele With a Mussel Inspired Reverse Thermal Gel》 was written by Bardill, James R.; Park, Daewon; Marwan, Ahmed I.. Safety of Di(1H-imidazol-1-yl)methanone And the article was included in Journal of Surgical Research in 2020. The article conveys some information:

Myelomeningocele (MMC) is an open neural tube defect of the spinal column. Our laboratory previously introduced a reverse thermal gel (RTG) as the first in situ forming patch for in utero MMC application. To overcome the challenges of anchoring the RTG in the wet amniotic environment to improve MMC coverage, we modified the RTG to mimic the underwater adhesive properties of mussels. We have separated this study into three sep. hypotheses-based components:Based on mussel inspired chem., modification of the RTG with dopamine will increase the underwater adhesive properties to improve RTG anchoring ability in a wet environment. Methods: The dopamine-modified RTG (DRTG) was synthesized using carbonyldiimidazole chem. and characterized with proton NMR, Fourier transform IR spectroscopy, and UV-visible spectroscopy. Rheol. and underwater adhesive tests measured mech. properties. Results: DRTG synthesis was confirmed with proton NMR, Fourier transform IR spectroscopy, and UV-visible spectroscopy. Rheol. demonstrated increased elasticity. Underwater adhesion testing revealed DRTG has similar wet adhesive strength to Tisseel fibrin sealant.The DRTG will support in vitro skin cell growth and will be safe for injection in a mouse animal model. Methods: Biocompatibility testing included 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, DRTG-fibroblast and keratinocyte cultures, and s.c. injections to quantify macrophages stained with immunohistochem. Results: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and DRTG cell cultures revealed no cytotoxicity and demonstrated the growth of fibroblasts and keratinocytes. S.c. injections cause a macrophage response that decreases after 4 wk.In utero injection of novel DRTG into a mouse MMC model will be effective with improved patch coverage of the MMC defect. Methods: MMC coverage by DRTG was assessed using in utero mouse injections in the Grainy head-like 3 (Grhl3) mouse model. Results: In utero Grhl3 mouse injections demonstrate statistically significant (P = 0.012) improved MMC coverage of DRTG compared with previous RTG coverage with no significant macrophage response.The DRTG demonstrates increased elasticity, cellular scaffolding properties, and improved MMC coverage in the Grhl3 mouse model. Future studies will be translated to the preclin. ovine model to evaluate this novel gel. In addition to this study using Di(1H-imidazol-1-yl)methanone, there are many other studies that have used Di(1H-imidazol-1-yl)methanone(cas: 530-62-1Safety of Di(1H-imidazol-1-yl)methanone) was used in this study.

Di(1H-imidazol-1-yl)methanone(cas: 530-62-1) is a coupling agent in the synthesis of dipolar polyamides for nonlinear optical applications and polypeptides. It also used to make β-keto sulfones and sulfoxides, lead sequestering agents, and β-enamino acid derivatives.Safety of Di(1H-imidazol-1-yl)methanone

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem

《The biotin biosynthetic pathway in Mycobacterium tuberculosis is avalidated target for the development of antibacterial agents》 was written by Bockman, Matthew R.; Mishra, Neeraj; Aldrich, Courtney C.. Product Details of 58-85-5 And the article was included in Current Medicinal Chemistry in 2020. The article conveys some information:

Mycobacterium tuberculosis, responsible for Tuberculosis (TB), remains the leading cause of mortality among infectious diseases worldwide from a single infectious agent, with an estimated 1.7 million deaths in 2016. Biotin is an essential cofactor in M. tuberculosis that is required for lipid biosynthesis and gluconeogenesis. M. tuberculosis relies on de novo biotin biosynthesis to obtain this vital cofactor since it cannot scavenge sufficient biotin from a mammalian host. The biotin biosynthetic pathway in M. tuberculosis has been well studied and rigorously genetically validated providing a solid foundation for medicinal chem. efforts. This review examines the mechanism and structure of the enzymes involved in biotin biosynthesis and ligation, summarizes the reported genetic validation studies of the pathway, and then analyzes the most promising inhibitors and natural products obtained from structure-based drug design and phenotypic screening. The results came from multiple reactions, including the reaction of 5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid(cas: 58-85-5Product Details of 58-85-5)

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid(cas: 58-85-5) may be used to elute proteins from avidin/streptavidin resins. It has been used for culturing of oligodendrocytes.Product Details of 58-85-5 And it has been used for blocking endogenous biotin during immunohistology procedures.

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem